VetterSW., Terentis AC., Osborne RL., Dawson JH., Goodin DB.; Replacement of the axial heme ligand with cysteine in nitrophorine 1: spectroscopic and crystallographic characterization,Journal of Inorganic Biochemistry, (2008), in press (reprint)
Leclerc E., Vetter SW.; Conformational changes and development of proteinase K resistance in surface-immobilized PrP; Archive of Virology, 153 (2008), 683-691 (reprint)
Brenk R., Vetter SW., Boyce SE., Goodin DB., Stoichet BK.; Probing molecular docking in a charged model binding site; Journal of Molecular Biology, 357 (2006), 1449-1470 (reprint)
Vetter SW., Leclerc E.; Novel aspects of calmodulin target recognition and activation; European Journal of Biochemistry, 270 (2003), 404-414 (reprint)
Vetter SW., Zhang ZY.; Combinatorial chemistry and peptide library methods to characterize protein phosphatases; Methods in Enzymology, 366 (2003), 260-282 (reprint)
Vetter SW., Zhang ZY.; Probing the phosphopeptide specificities of protein tyrosine phosphatases, SH2 and PTB domains with combinatorial library methods; Current Protein and Peptide Science, 3 (2002), 365-397 (reprint)
Leclerc E., Liemann S., Wildergger G., Vetter SW., Nilsson F.; Selection and characterization of single chain Fv fragments against murine recombinant prion protein from asynthetic human antibody phage display library; Human Antibodies, 9 (2000), 207-214 (reprint)
Vetter SW., Keng YF., Lawrence DS., Zhang ZY.,; Assessment of protein-tyrosine phosphatase 1B substrate specificity using "inverse alanine scanning"; Journal of Biological Biology; 275 (2000), 2265-2268 (reprint)
Sarimiento M., Puius YA., Vetter SW., Keng YF., Wu L., Zhao Y., Lawrence DS., Almo SC., Zhang ZY.; Structural basis for pplasticity in protein tyrosine phosphatase 1B substrate recognition; Biochemistry, 39 (2000), 8171-8179 (reprint)
Vetter, SW.; Proteinchemie: What's up?; Biospektrum, 6 (2000), 346
Leclerc E., Corti C., Schmid H., Vetter S. James P., Carafoli E.; Serine /threonine phosphorylation of calmodulin modulates its interaction with the binding domains of targetr enzymes; Biochemical Journal;344 (1999), 403-411 (reprint)
Lehmann E., Zenobi R., Vetter S.; Matrix-assisted laser desorption/ionization mass spectra reflect solution-phase zinc finger peptide complexation; Journal of the American Society for Mass Spectrometry; 10 (1999); 27-34 (reprint)
Vetter S.; High-affinity non-inhibitory ligands for alkaline phosphatase revealed from a restricted heptapeptide library. In: Epton R (Ed) Solid Phase Synth. Comb. Libr. (1999) Mayflower Sci. Ltd, Kingswingord, UK, pp 407-410
Vetter S., Schmid H.; High affinity binding peptides for phosphatase. In: Tam JP, Kaumaya PP (Eds) Pept. Proc. Am. Pept. Symp. 15th. (1999) Kluwer, Dordrecht, NL, pp 71-72
Schmid H, Hoving S, Vetter S, Vorherr T, Carafoli E (1999) Synthesis and purification of unphosphorylated and phosphorylated phospholamban. In: Tam JP, Kaumaya PP (Eds) Pept. Proc. Am. Pept. Symp. 15th. (1999) Kluwer, Dordrecht, NL, pp 709-710
Leclerc E., Vetter S.; Characterization of a calcium-dependent calmodulin-binding domain in the 135-kD human protein 4.1 isoform; European Journal of Biochemistry; 258 (1998), 567-571 (reprint)
Vetter S.; Direct synthesis of di-and trimethoxybenzyl thiols from the coressponding alcoholp; Synthetic Communications; 28 (1998), 3219-3223 (reprint)
Vetter S.,Bayer EA., Wilchek M.; Avidin can be forced to adopt catalytic activity; Journal of the American Chemical Society; 116 (1994), 9369-9370 (reprint)
31. Sturchler, E., Galichet, A., Weibel, M., Leclerc, E. and Heizmann, C.W. (2008), J. of Neuroscience. Site Specific Blockade of RAGE-Vd prevents amyloid-beta oligomers neurotoxicity. In press
30. Leclerc, E. and Vetter, S. (2008), Arch. Virol. 153, 683-691. Conformational changes and development of proteinase K resistance in surface-immobilized PrP. (reprint)
29. Buetler, T.M., Leclerc, E., Baumeyer, A., Latado, H., Newell, J., Adolfsson, O., Parisod, V., Richoz, J., Maurer, S., Foata, F., Piguet, D., Junod, S., Heizmann, C.W. and Delatour, T. (2008), Molecular Nutrition and Food Research 52, 370-378. N-carboxymethyllysine-modified proteins are unable to bind to RAGE and activate an inflammatory response.
28. Leclerc, E., Sturchler, E. and Heizmann, C.W. Book chapter: Calcium Regulation by EF-hand Proteins in the Brain. In Handbook of Neurochemistry and Molecular Biology, Springer-Verlag Eds., Berlin Heidelberg. In press.
27. Leclerc, E., Fritz, G., Weibel, M, Heizmann, C.W. and Galichet, A. (2007), J. Biol. Chem. 282, 31317-31331, S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE immunoglobulin domains.
26. Dattilo, B.M., Fritz, G., Leclerc, E., Kooi, C.W., Heizmann, C.W. and Chazin, W.J. (2007), Biochemistry 46, 6957-6970, The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units.
25. Ostendorp, T., Weibel, M., Leclerc, E., Kleinert, P., Kroneck, P.M.H., Heizmann, C.W. and Fritz, G. (2006), Biochem. Biophys. Res. Comm. 347, 4-11, Expression and purification of the soluble isoform of human receptor for advanced glycation end products (sRAGE) from Pichia pastoris.
24. Leclerc, E., Serban, H., Prusiner, S.B., Burton, D.R. and Williamson, R.A. (2006), Arch. Virol. 151, 2103-9. Copper induces conformational changes in the N-terminal part of cell-surface PrPC.
23. Vetter, S.W. and Leclerc, E. (2003), Eur. J. Biochem. 270, 404-414, Novel aspects of Calmodulin target recognition and activation.
22. Peters, P.J., Mironov, A.Jr., Peretz, D., van Donselaar, E., Leclerc, E., Erpel, S., DeArmond, S.J., Burton, D.R., Williamson, R.A., Vey, M. and Prusiner, S.B. (2003), J. Cell. Biol. 162, 703-717. Trafficking of prion proteins through a caveolae-mediated endosomal pathway.
21. Leclerc, E., Peretz, D., Ball, H., Solforosi, L., Legmane, G., Safar, J., Prusiner, S.B., Burton, D.R. and Williamson, R.A. (2003), J. Mol. Biol. 326, 475-483. Conformation of PrPC on the cell surface as probed by antibody.
20. Safar, J., Scott, M., Monaghan, J., Deering, C., Didorenko, S., Vergara, J., Ball, H., Legmane, G., Leclerc, E., Solforosi, L., Serban, H., Groth, D., Burton, D.R., Prusiner, S.B. and Williamson, R.A. (2002), Nature Biotechnology 20, 1147-50. Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice.
19. Nandi, P.K., Leclerc, E., Nicole, J.-C and Takahashi, M. (2002), J. Mol. Biol. 322, 153-161. DNA-induced partial unfolding of prion protein leads to its polymerisation to amyloid.
18. Nandi, P.K., Leclerc, E. and Marc, D. (2002), Biochemistry, 41, 11017-11024. Unusual property of Prion protein unfolding in neutral salt solution.
17. Williamson, R.A., Burgoon, M.P., Owens, G.P., Ghausi, O., Leclerc, E., Firme, L., Carlson, S., Corboy, J., Parren, P.W., Sanna, P.P., Gilden, D.H. and Burton, D.R. (2001), Proc. Natl. Acad. Sci. USA. 98, 1793-1798. Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis.
16. Leclerc, E., Peretz, D., Ball, H., Sakurai, H., Legname, G., Serban, A., Prusiner, S.B., Burton, D.R. and Williamson, R.A. (2001), EMBO J., 45, 1547-1554. Immobilized prion protein undergoes spontaneous rearrangement to a conformation having features in common with the infectious form.
15. Vetter, S.W. and Leclerc, E. (2001), Eur. J. Biochem., 268, 1-9. Phosphorylation of serine residues affects the conformation of the calmodulin binding domain of human protein 4.1.
14. Peretz, D., Williamson, R.A., Kaneko, K., Vergara, J., Leclerc, E., Schmitt-Ulms, G., Mehlhorn, I., Legname, G., Wormald, M.R., Rudd, P.M., Dwek, R.A., Burton, D.R. and Prusiner, S.B. (2001), Nature, 412, 739-743. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity.
13. Leclerc, E., Liemann, S., Wildegger, G., Vetter, S.W. and Nilsson, F. (2000), Human Antibodies, 9, 207-214. Selection and characterization of single chain Fv fragments against murine recombinant prion protein from a synthetic human antibody phage display library. (reprint)
12. Corti, C., Leclerc-L'Hostis, E., Quadroni, M., Schmid, H., Durussel, I., Cox, J., Dainese Hatt, P., James, P. and Carafoli, E:, (1999), Eur. J. Biochem. 262, 790-802.Tyrosine phosphorylation modulates the interaction of calmodulin with its target proteins.
11. Leclerc, E., Corti, C., Schmidt, H., Vetter, S., James, P. and Carafoli, E., (1999), Biochemical J. 344, 403-411. Serine/threonine phosphorylation of calmodulin modulates its interaction with the binding domains of target enzymes. (reprint)
10. Nandi, P.K. and Leclerc, E. (1999) Arch. Virol. 144, 1751-1763. Polymerisation of murine recombinant prion protein in nucleic acid solution.
9. Leclerc, E. and Vetter, S.(1998) Eur. J. Biochem. 258, 567-571. Characterization of a calcium-Dependent Calmodulin Binding Domain in the 135 kD human Protein 4.1 isoform. (reprint)
8. Quadroni, M., Leclerc-L’Hostis, E., Corti, C., Myagkikh, I., James, P. and Carafoli, E. (1998), Biochemistry 37, 6523-6532. Phosphorylation of Calmodulin alters its potency as an activator of target enzymes.
7. Leclerc-L'Hostis E., Leclerc L., Haiech J., Poyart C: and Marden M.C. (1996) Biochimica and Biophysica Acta 1313, 209-216. Heme-CO binding to tryptophan-containing calmodulin mutants.
6. Leclerc-L'Hostis E., Franzen S., Lambry J-C., Martin M., Leclerc L., Poyart C. and Marden M.C. (1996), Biochemica and Biophysica Acta. 1293, 140-146. Picosecond Geminate Recombination of CO after Photodissociation from the Complexes Calmodulin*Heme-CO and Calmodulin*Heme-CO*Melittin.
5. Zaidi A., Leclerc-L'Hostis E., Marden M.C., Poyart C. and Leclerc L. (1995) Biochemica and Biophysica Acta, 1236, 114-118. Heme as an optical probe for studying the interactions between calmodulin and the Ca2+-ATPase of the human erythrocyte menbrane.
4. Marden M.C., Dufour, E., Christova, P., Huang, Y., Leclerc-L'Hostis E. and Haertle T. (1994), Archives of Biochemistry and Biophysics 311, 258-262. Binding of Heme-CO to Bovine and Porcine beta-Lactoglobulins.
3. Leclerc E., Leclerc L., and Marden M.C. (1993) Journal of Fluorescence 3, 45-49. Asymmetry of Calmodulin Revealed by Peptide Binding.
2. Leclerc E., Leclerc L., Poyart C., and Marden M.C.(1993), Archives of Biochemistry and Biophysics 306, 158-162. Interaction of Heme with Amphiphilic Peptides: Use of Hemin-CN to Probe the Interaction of Calmodulin with its Target Peptides.
1. Leclerc E., Leclerc L., Cassoly R., der Terrossian E., Wajcman H., Poyart C. and Marden M.C. (1993), Archives of Biochemistry and Biophysics 306, 163-168. Heme Binding to Calmodulin, Troponin C and Parvalbumin, as a Probe of Calcium-Dependent Conformational Changes.
|